LPL Financial
RPRX icon

LPL Financial’s Royalty Pharma RPRX Stock Holding History

LPL Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Buy
249,117
+51,186
+26% +$2.66M ﹤0.01% 1842
2026
Q1 		$9.49M Buy
197,931
+83,050
+72% +$3.64M ﹤0.01% 2042
2025
Q4 		$4.44M Buy
114,881
+7,256
+7% +$277K ﹤0.01% 2631
2025
Q3 		$3.8M Buy
107,625
+54,650
+103% +$1.98M ﹤0.01% 2726
2025
Q2 		$1.91M Sell
52,975
-16,166
-23% -$536K ﹤0.01% 3170
2025
Q1 		$2.15M Buy
69,141
+45,236
+189% +$1.43M ﹤0.01% 2893
2024
Q4 		$610K Sell
23,905
-2,859
-11% -$75.8K ﹤0.01% 3917
2024
Q3 		$757K Sell
26,764
-18,294
-41% -$507K ﹤0.01% 3653
2024
Q2 		$1.19M Buy
45,058
+16,207
+56% +$449K ﹤0.01% 3093
2024
Q1 		$876K Buy
28,851
+8,327
+41% +$245K ﹤0.01% 3307
2023
Q4 		$577K Buy
20,524
+5,241
+34% +$144K ﹤0.01% 3555
2023
Q3 		$415K Sell
15,283
-3,555
-19% -$106K ﹤0.01% 3633
2023
Q2 		$579K Buy
18,838
+296
+2% +$10K ﹤0.01% 3316
2023
Q1 		$668K Buy
18,542
+10,984
+145% +$407K ﹤0.01% 3109
2022
Q4 		$299K Sell
7,558
-2,337
-24% -$97.5K ﹤0.01% 3651
2022
Q3 		$398K Buy
9,895
+763
+8% +$32.6K ﹤0.01% 3353
2022
Q2 		$384K Buy
9,132
+2,201
+32% +$90.2K ﹤0.01% 3430
2022
Q1 		$270K Sell
6,931
-789
-10% -$31K ﹤0.01% 3643
2021
Q4 		$308K Buy
+7,720
New +$300K ﹤0.01% 3664
2021
Q1 		– Sell
-5,694
Closed -$285K – 4137
2020
Q4 		$285K Sell
5,694
-14,056
-71% -$596K ﹤0.01% 3243
2020
Q3 		$831K Buy
19,750
+10,867
+122% +$466K ﹤0.01% 2089
2020
Q2 		$431K Buy
+8,883
New +$440K ﹤0.01% 2527

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's RPRX Position: Q2 2026 in Review

LPL Financial increased its Royalty Pharma (RPRX) stake by 26% in Q2 2026, buying an estimated $2.66M and bringing the position to 249,117 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

LPL Financial first reported a position in RPRX in Q2 2020 and has held it in 22 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • LPL Financial held 249,117 shares of Royalty Pharma worth $14M as of Q2 2026.
  • LPL Financial bought 51,186 Royalty Pharma shares in Q2 2026, an estimated $2.66M.
  • Royalty Pharma made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #1842 holding.
  • LPL Financial first reported a position in Royalty Pharma in Q2 2020 and has held it in 22 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.